About Enbiome Therapeutics

About company

EnBiome is a precision microbiotics company with a powerful screening platform for a continuous pipeline of products of therapeutic value, selectively for either prescription or non-prescription path to market. The vision of the company is to become a leading precision microbiome product company that revolutionizes the approach to microbiome drug development and its positive impact on human health. The company is founded on over four years of scientific research with 3 prioritized products ready for pre-clinical development. Their three key differentiation factors make us the trailblazers in the microbiome drug development field.